ILSON David

Mattehorn study showed EFS improvement and strong OS trend with FLOT+duravalumab. Great news to establish the global standard for fit patients with locally advanced gastric/GEJ cancer. Looking forward to the detail.@OncoAlert @oncodaily astrazeneca.com/media-centre/p…

Boston Mayor Michelle Wu is a fucking star. 🙌🙏💪👏👊👇

We're excited to kick off the @MSKCancerCenter 2025 Update in #Hematology and #MedicalOncology and 13th Annual Board Review this Friday. Join us for an engaging program led by renowned faculty. Explore the full agenda at bit.ly/HemOnc2025. #MSKHemOncCME @ILSONDavid, @GABOUALFA, @AndreaCercek, @alissajcooper, @JoshDragoMD, @DrDarrenFeldman, @MalinHultcrantz, @LeaderAvi, @anitamamtani, @mjmauroMD, @motzermd, @michael_offin, @EileenMOReilly, @RaajitRampal, @GunjanLShah, @SoffGerald, @StadlerZsofia, @MCThompsonMD, @AnnaVarghese4, @cywilkinsmd

ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with HER2 Positive Metastatic Gastric Cancer at Interim Analysis of DESTINY- Gastric04 Phase 3 Trial 👉ENHERTU more effective than Pacli/Ram daiichisankyo.com/files/news/pre… @myESMO

Thirty-two years together and you still take my breath away. Happy Valentine’s Day, @MichelleObama!

Whether preparing for board certification or seeking a thorough review, don’t miss the 13th Annual Board Review and Comprehensive Update in #Hematology & #MedicalOncology this March. This intensive 3.5-day virtual course delivers an up-to-date, expert-led review. Learn more: bit.ly/HemOnc2025 #MSKHemOncCME @MSKCancerCenter @MSK_DeptOfMed @ILSONDavid @GABOUALFA @AndreaCercek @alissajcooper @DrDarrenFeldman @MalinHultcrantz @LeaderAvi @anitamamtani @mjmauroMD @motzermd @michael_offin @EileenMOReilly @RaajitRampal @StadlerZsofia @MCThompsonMD @AnnaVarghese4 @cywilkinsmd

Very grateful that those oncologists who inspire me to #endcancer also happen to be incredible humans! Thanks to all for coming out in SF to celebrate life and love! ❤️🌈 #GI25

Ipi nivo is the new first line SOC treatment for MSI High metastatic colorectal cancer.

👏 Great to see this published! VESTIGE is a negative randomised trial with an important lesson.. ➡️ Give adjuvant FLOT even when there's residual cancer after neoadjuvant chemo. 👀 Looking forward to the translational work annalsofoncology.org/article/S0923-…

💵 Baselined: The Biden Economy We are taking a snapshot of Joe Biden's economy before he leaves office so we have a point of comparison when Donald Trump begins to take credit for it, like he did the economy he inherited form Barack Obama.

I am thankful to @NEJM for promoting the science presented at @myESMO Congress in Barcelona

It's a beautiful sunrise as we prepare to leave Barcelona after #ESMO24. Thanks to @myESMO @RebeccaDSing @AndresC27622123 @KKronig #ESMOAmbassadors for a super successful meeting!

Niche 2 after two doses of nivolumab and one dose of ipi and surgery. 100% of patients with MSI high colon cancer relapse free at 3 years. Arguably preop IO should be a new care standard in MSI high colon cancer.

Time to move away from radiotherapy in operable GEA #ESMO24 TOPGEAR ➡️ no survival benefit when RT added to periop chemo TOPGEAR + ESOPEC : both great trials with a definitive answer = no more RT ✅Great drugs in development - let's focus on systemic Rx for cure @myESMO

Results of TOPGEAR trial indicate no survival benefit for adding radiation therapy to perioperative chemotherapy in gastroesophageal adeno carcinoma. Chemotherapy alone should be the standard of care with chemo radiotherapy only used in the nonoperative setting. ESMO 2024

We’re fired up and ready to go! Let’s do all we can to elect @KamalaHarris and @Tim_Walz. Join us: KamalaHarris.com

The force is definitely with us in Chicago. Awesome to see @MarkHamill aka Luke Skywalker at the DNC convention.

@ILSONDavid powers through GEJ and CRC data from ASCO for us in a clear, nuanced way: "ESOPEC is practice changing!' @AdventHealthCFL